Patents by Inventor Hanlin WEI

Hanlin WEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260217766
    Abstract: Disclosed herein is a series of cyclic peptide PCSK9 inhibitors, along with methods of using the same and therapeutic applications thereof in the treatment of cardiovascular diseases, hypercholesterolemia, and related disorders.
    Type: Application
    Filed: March 19, 2025
    Publication date: July 30, 2026
    Inventors: Fanglin LI, Shibin ZHUANG, Weijun ZHONG, Qiang LUO, Zonglian LIN, Jinhao XIE, Xingyi LIN, Hanlin WEI, Borui ZHAN, Shanjia LI, Xinyue SHEN, Dongmei HE, Renchong YAO, Shenghong HUANG, Yan CHEN, Chester Chenguang YUAN
  • Publication number: 20250058219
    Abstract: A virtual character control method and an electronic device thereof. The method includes: displaying a first attack control on a graphical user interface; in response to detecting a first touch-control operation acting on the first attack control, determining whether the first touch-control operation is a click operation or a sliding operation; in response to determining that the first touch-control operation is the click operation, controlling a virtual character to perform a first attack action corresponding to the first attack control; and in response to determining that the first touch-control operation is the sliding operation, determining a first target action from a first action set according to the sliding operation, and controlling the virtual character to perform the first target action.
    Type: Application
    Filed: May 15, 2023
    Publication date: February 20, 2025
    Applicant: NETEASE (HANGZHOU) NETWORK CO., LTD.
    Inventors: Lei KUAN, Hanlin WEI, Xutao HU, Chen GONG, Tao CHEN
  • Publication number: 20250011365
    Abstract: The present invention discloses a new compound, such as a compound of formula I, or a pharmaceutically acceptable salt thereof or an isomer thereof. The compound has a good fungal inhibitory effect, can be used for effectively preventing or treating fungal infections, and is a new generation of echinocandin-based drugs with higher efficiency.
    Type: Application
    Filed: December 29, 2023
    Publication date: January 9, 2025
    Inventors: Yiguo ZHOU, Haoyu ZHANG, Conghui PENG, Hanlin WEI, Shenghong HUANG, Renchong YAO, Chester Chenguang YUAN